489 GMTIn adults, geometric mean titres of Zaire Ebola virus glycoprotein-specific antibodies at day 28 were 489 (95% CI: 264–908) for the 3 × 10⁴ PFU dose.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
Explore evidence
Gold tier: mechanically validated evidence, with its primary source.
19 evidence items · page 1 / 1
22 %Twenty-two percent of adults had a ≥4-fold increase of Zaire Ebola virus antibodies at day 28.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
1,245 GMTIn adults, geometric mean titres of Zaire Ebola virus glycoprotein-specific antibodies at day 28 were 1,245 (95% CI: 899–1,724) for the 3 × 10⁶ PFU dose.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
1,015 GMTGeometric mean titres of Zaire Ebola virus antibodies at day 28 in adults were 1,015 (95% CI: 647–1,591) for the 3 × 10⁴ PFU dose.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
1,503 GMTIn adults, geometric mean titres of Zaire Ebola virus glycoprotein-specific antibodies at day 28 were 1,503 (95% CI: 931–2,426) for the 2 × 10⁷ PFU dose.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
1,620 GMTThe vaccine induced geometric mean titres of Zaire Ebola virus glycoprotein-specific antibodies of 1,620 (95% CI: 806–3,259) at day 28 in children.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
3,958 GMTGeometric mean titres of Zaire Ebola virus antibodies at day 28 in adults were 3,958 (95% CI: 2,249–6,967) for the 2 × 10⁷ PFU dose.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
11 %Before vaccination, Zaire Ebola virus glycoprotein-specific antibodies were detected in 11% of adults.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
3.5 %Prevalence of Zaire ebolavirus-specific immunoglobulin M antibodies was 3.5% in chimpanzees in regions of Gabon where previous human outbreaks of Ebola virus disease occurred between 1994 and 2002.
Gabonmaladie à virus Ebolaobserved 1994–2002published 2020Viruseseurope_pmcdocument of 4 observationsDOI 10.3390/v12121347
95 %Lors des crises sanitaires récentes au Gabon et au Congo, le taux de mortalité chez les gorilles dus au virus Ébola a augmenté de 95 %.
Gabonmaladie à virus EbolaHAL · Unilimdocument of 182 observations
1,428 GMTThe vaccine induced geometric mean titres of Zaire Ebola virus glycoprotein-specific antibodies of 1,428 (95% CI: 1,025–1,989) at day 28 in adolescents.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
1,887 GMTGeometric mean titres of Zaire Ebola virus antibodies at day 28 in adults were 1,887 (95% CI: 1,154–3,085) for the 3 × 10⁵ PFU dose.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
74 %In adults, 74% to 100% of individuals who received a vaccine dose of 3 × 10⁴, 3 × 10⁵, 3 × 10⁶, or 2 × 10⁷ PFU had a ≥4.0-fold increase in geometric mean titres of Zaire Ebola virus glycoprotein-specific antibodies at day 28.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
50 %Neutralising antibodies were detected in more than 50% of participants at vaccine doses ≥3 × 10⁵ PFU.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
1,445 GMTGeometric mean titres of Zaire Ebola virus antibodies at day 28 in adults were 1,445 (95% CI: 1,013–2,062) for the 3 × 10⁶ PFU dose.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
556 GMTIn adults, geometric mean titres of Zaire Ebola virus glycoprotein-specific antibodies at day 28 were 556 (95% CI: 280–1,101) for the 3 × 10⁵ PFU dose.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
31.2 %Local prevalence of anti-Zaire ebolavirus immunoglobulin G antibodies was 31.2% in gorilla samples in regions of Gabon where previous human outbreaks of Ebola virus disease occurred between 1994 and 2002.
Gabonmaladie à virus Ebolaobserved 1994–2002published 2020Viruseseurope_pmcdocument of 4 observationsDOI 10.3390/v12121347
27 %Before vaccination, Zaire Ebola virus antibodies were detected in 27% of adults.
Gabonmaladie à virus Ebolapublished 2017PLoS medicineeurope_pmcdocument of 17 observations
15.3 %A serological survey found a Zaire ebolavirus-specific IgG seroprevalence of 15.3% among 4,349 rural individuals in Gabon.
Gabonmaladie à virus Ebolapublished 2010PLoS ONEOpenAlexdocument of 7 observationsDOI 10.1371/journal.pone.0009126
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.